BTS' Jungkook is making waves again with his brand getting trademarked in several big nations, including the US and EU.

Sylogist's new logo growth and cross-selling strategies make it an attractive investment with strong IRR potential despite near-term headwinds. See more here.

By approving magnet-free 'Qi2 Ready' marketing, the Wireless Power Consortium sets consumers up for confusion and bends the ...

Business-to-business advertisers can now precisely target high-value audiences within Quora's 400 million monthly unique ...

The uniforms aren't changing, but new patches are available to cover the organization's old name, which is sewn onto the ...

Yields edged up this week after a hotter-than-expected inflation report. Some traders are now eyeing the 10-year bond hitting ...

Volkswagen will unveil the electric T-Cross at IAA Mobility, dubbed the ID.2X. CEO Thomas Schäfer confirmed the ...

If costs are going up because consumers feel confident enough to finance big ticket items, Sarah House at Wells Fargo says ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Wall Street approaches record levels as investors navigate mixed economic signals and corporate earnings reports.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...